International Journal of Biological Sciences

Impact factor
3.873

ISSN 1449-2288

News feeds of IJBS published articles
My Manuscript
My Account

Journal of Biomedicinenew

Theranostics

International Journal of Medical Sciences

Journal of Cancer

Oncomedicine

Journal of Genomics

Journal of Bone and Joint Infection (JBJI)

Nanotheranostics

PubMed Central Indexed in Journal Impact Factor

Int J Biol Sci 2015; 11(11):1269-1271. doi:10.7150/ijbs.13395

Letter

Serum C3 Enhances Complement Receptor 3-Mediated Phagocytosis of Borrelia burgdorferi

Kelly L. Hawley1*, Chris M. Olson Jr.1#, Ana Carreras-González2, Nicolás Navasa2, Juan Anguita1,2,3 Corresponding address

1. Department of Veterinary and Animal Sciences, University of Massachusetts Amherst, 01003 Amherst, MA, USA
2. CIC bioGUNE, Bizkaia Technology Park, 48160 Derio, Spain
3. IKERBASQUE, Basque foundation for science, 48013 Bilbao, Spain
* KLH present address: UCONN Health Center, 263 Farmington Ave. Farmington, CT
# CMOJ present address: Mayo Medical School, 200 First St SW. Rochester, MN.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Hawley KL, Olson CM Jr., Carreras-González A, Navasa N, Anguita J. Serum C3 Enhances Complement Receptor 3-Mediated Phagocytosis of Borrelia burgdorferi. Int J Biol Sci 2015; 11(11):1269-1271. doi:10.7150/ijbs.13395. Available from http://www.ijbs.com/v11p1269.htm

 

Complement receptor (CR) 3 is a bona fide phagocytic receptor for Borrelia burgdorferi, the causative agent of Lyme borreliosis [1, 2]. CR3 is also the receptor for the opsonin iC3b, a final degradation product of the complement component C3 [3, 4]. The transit of B. burgdorferi through the blood during the dissemination phase exposes the spirochete to serum components, including complement [5]. B. burgdorferi contains proteins with anti-complement activities that trigger the inactivation of C3b through the binding of factor H (FH) on the surface of the bacterium [6]. This could lead to the accumulation of the opsonin, iC3b, and the enhanced phagocytosis of the spirochete. To test whether the presence of serum would increase the phagocytosis of B. burgdorferi, we incubated bone marrow-derived macrophages (BMMs), generated as described [1], with heat-inactivated (HI; 56 ºC, 30 min) or active normal mouse sera (NMS). Phagocytosis protocols were followed according to published reports [1, 2]. The presence of 10% HI serum resulted in phagocytosis levels comparable to those in the absence of serum (Fig. 1A,B). However, the presence of 10 % NMS enhanced the capacity of macrophages to internalize B. burgdorferi (Fig. 1A). The same effect was observed on RAW264.7 (RAW) cells (Fig. 1C). Thus, the contact of B. burgdorferi with serum components results in their enhanced phagocytic uptake. Next, we assessed whether the increased phagocytic activity associated with the presence of serum was due to C3-derived opsonin generation. We used sera from C3-deficient mice (C3 KO), in which B. burgdorferi dissemination is enhanced compared to WT mice [5]. The presence of C3 KO serum abrogated the increased phagocytosis observed in the presence of NMS, both in BMMs (Fig. 1A,B) and RAW cells (Fig. 1C).

To demonstrate that the enhanced phagocytosis of B. burgdorferi in the presence of NMS was specific to CR3, we used CHO cells transfected with human CR3 (CD11b/CD18; CHO-CR3) or CR4 (CD11c/CD18; CHO-CR4) as controls [1, 7]. Incubation of CHO-CR3, but not CHO-CR4, cells resulted in increased binding of the spirochete (Fig. 2A). Furthermore, the presence of a blocking CD11b antibody (M1/70) [1] also resulted in the reduction of B. burgdorferi phagocytosis in the presence of NMS in RAW cells (Fig. 2B). We also used BMMs generated from CD11b KO mice. Consistently, the presence of NMS during phagocytosis failed to increase the phagocytosis of B. burgdorferi in the absence of CD11b, compared to the use of HI serum (Fig. 2C), demonstrating that sera increased the phagocytosis of B. burgdorferi through its interaction with CR3.

We have demonstrated that CR3-mediated phagocytosis tempers the inflammatory output of macrophages [1]. We argued that the CR3-dependent boost in phagocytosis in the presence of NMS would also reduce the production of TNF in response to B. burgdorferi. We stimulated BMMs with live B. burgdorferi at an m.o.i. of 25 for 16 h in the presence of NMS or C3-deficient serum. The presence of NMS significantly reduced the production of TNF by BMMs (Fig. 2D). Importantly, the absence of C3 abrogated this inhibitory effect (Fig. 2D). The effect of active serum on macrophages was specific for TNF, since the levels of IL-6 did not change in the presence of active serum (Fig. 2E). Furthermore, the effect was specific of ligands that interact with CR3, since the presence of serum did not result in changes in the levels of TNF produced by BMMs in response to the TLR4 agonist, LPS (Fig. 2F). Overall, these data demonstrate that CR3 is an anti-inflammatory phagocytic receptor both in the absence [1] and the presence of the opsonin iC3b.

In summary, our results show that serum C3-derived opsonins enhance the phagocytosis of B. burgdorferi mediated by CR3 further tempering the inflammatory output of macrophages induced by the integrin.

 Figure 1 

Serum increases phagocytosis of B. Burgdorferi in a C3-dependent manner. (A) BMMs were incubated with GFP-expressing B. burgdorferi (Bb914) at an m.o.i. of 50, in the presence of 10% HI (blue histogram), NMS (red histogram), C3-deficient serum (orange histogram) or without serum (green histogram). Phagocytosis was allowed to occur for 4h (BMMs) or 6h (RAW cells), followed by analysis by flow cytometry. The data were analyzed using FlowJo version 10. The average mean fluorescence intensity was evaluated in triplicates for BMMs (B) and RAW cells (C). The grey histogram/bars represent a 4 ºC control. The data presented represent one representative experiment of at least 3 performed.

Int J Biol Sci Image (Click on the image to enlarge.)
 Figure 2 

Serum-mediated increase of B. Burgdorferi phagocytosis is CR3 dependent. (A) CHO-CR3 (bottom panel) and CHO-CR4 (top panel) cells were incubated with Bb914 (m.o.i. = 50) in the presence of HI (blue histogram) or NMS (red histogram). After 6 h, the binding of B. burgdorferi was determined by flow cytometry. (B) RAW cells were incubated with Bb914 in the presence of HI (blue histogram), NMS (red histogram) or NMS + 10 μg/mL of a blocking CD11b antibody (green histogram). After 2 h, the cells were analyzed by flow cytometry. (C) CD11b-deficient BMMs were incubated with Bb914 in the presence of HI (blue histogram) or NMS (red histogram). The cells were analyzed by flow cytometry after 4 h. The grey histograms represent a 4 ºC control. The data represent one of at least 3 independent experiments performed in triplicate. (D) BMMs from C57Bl/6 mice were stimulated with live B. Burgdorferi (m.o.i. = 25) in the presence of NMS (blue bar) or C3-deficient serum (red bar). TNF levels in the stimulation supernatants were measured 16 h later by ELISA. (E, F) BMMs were stimulated with B. burgdorferi (m.o.i. = 25) or LPS (100 ng/mL) in the presence of HI (green bar) or NMS (blue bar) for 16h. The supernatants were assessed for IL-6 (E) and TNF (F) by ELISA.

Int J Biol Sci Image (Click on the image to enlarge.)

Acknowledgements

Supported by grants from the Spanish Ministry of Economy and Competitiveness (MINECO, SAF2012-34610), the American Heart Association (CMOJ) and a fellowship from the Basque Government (AC).

We thank Justin D. Radolf for providing the GFP-expressing B. burgdorferi and Erol Fikrig and Sam Black for generously providing C3-deficient sera.

Competing Interests

The authors have declared that no competing interest exists.

References

1. Hawley KL, Olson CM Jr, Iglesias-Pedraz JM, Navasa N, Cervantes JL, Caimano MJ, Izadi H, Ingalls RR, Pal U, Salazar JC. et al. CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi. Proc Natl Acad Sci U S A. 2012;109:1228-32

2. Hawley KL, Martin-Ruiz I, Iglesias-Pedraz JM, Berwin B, Anguita J. CD14 targets complement receptor 3 to lipid rafts during phagocytosis of Borrelia burgdorferi. Int J Biol Sci. 2013;9:803-10

3. Le Cabec V, Carreno S, Moisand A, Bordier C, Maridonneau-Parini I. Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J Immunol. 2002;169:2003-9

4. Ueda T, Rieu P, Brayer J, Arnaout MA. Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/CD18). Proc Natl Acad Sci U S A. 1994;91:10680-4

5. Lawrenz MB, Wooten RM, Zachary JF, Drouin SM, Weis JJ, Wetsel RA, Norris SJ. Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun. 2003;71:4432-40

6. Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P, Seppala IJ, Meri S. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem. 2001;276:8427-35

7. Medvedev AE, Flo T, Ingalls RR, Golenbock DT, Teti G, Vogel SN, Espevik T. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J Immunol. 1998;160:4535-42

Author contact

Corresponding address Corresponding author: janguitaes


Received 2015-7-30
Accepted 2015-9-3
Published 2015-9-11